Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
about
The circadian clock in cancer development and therapyST6Gal-I overexpression facilitates prostate cancer progression via the PI3K/Akt/GSK-3β/β-catenin signaling pathwayGSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cellsGSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway.
P2860
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@ast
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@en
type
label
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@ast
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@en
prefLabel
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@ast
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@en
P2093
P2860
P356
P1476
Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer.
@en
P2093
Ayako Kitano
Takeo Shimasaki
Toshinari Minamoto
Yoshiharu Motoo
P2860
P356
10.4103/1477-3163.100866
P407
P577
2012-09-13T00:00:00Z